<DOC>
	<DOCNO>NCT02631603</DOCNO>
	<brief_summary>Stop exogenous allergic alveolitis ( EAA ) childhood : healthy adulthood - randomize , double-blind , placebo-controlled , parallel-group study evaluate prednisolone treatment course disease . The hypothesis study treatment placebo inferior term Forced Vital Capacity ( FVC ) improvement treatment systemic steroid 6 month treatment .</brief_summary>
	<brief_title>Stop Exogenous Allergic Alveolitis ( EAA ) Childhood</brief_title>
	<detailed_description>Patients allocate two treatment , i.e. , oral prednisolone Placebo . Experimental intervention : Placebo Control intervention : Prednisolone Duration intervention per patient : 3 month Follow-up per patient : 3 month Primary Objective : To evaluate outcome EAA 6 month compare medium term treatment systemic steroid Placebo . Secondary Objectives : To evaluate completeness knowledge standardize pedantic allergen elimination family child EAA . To evaluate treatment EAA systemic steroid compare placebo 3 month . To evaluate safety treatment EAA outpatient usage systemic steroid compare Placebo .</detailed_description>
	<mesh_term>Alveolitis , Extrinsic Allergic</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>1 . Newly previously diagnose appropriately treat EAA child , adolescent young adult , age 3 25 year . The diagnosis EAA must confirm independent review finding expert panel must base presence least 4 follow finding : History appropriate allergen exposure Restrictive lung function ( FVC &lt; 80 % predict age FVC/FEV1 &lt; 1 ) testing , appropriate age ( usually &gt; 5 ) Positive serum precipitin bird/fungus expose ( allergen rarely , every demonstrated child ) Lymphocytosis BAL ( &gt; 20 % cell lymphocytes ) HRCT show characteristic nodular , linear reticular opacity , ground glass pattern increase attenuation . Lung biopsy demonstrate lymphocytic alveolitis , bronchiolitis , noncaseating histiocytic granulomatas . Controlled allergen exposure follow characteristic reaction , include fever , cough , restriction lung function , hypoxemia/desaturation rest exercise 2 . Unchanged inhaled steroid ; , plan introduce follow 6 month 3 . Agreement home visit independent study physician 1 . Contraindication usage systemic steroid 2 . Critically ill patient need respiratory support 3 . Noncompliance medical treatment intervention 4 . Women childbearing potential practicing medically accept contraception trial positive pregnancy test ( serum urine ) end trial . Reliable contraception systematic contraceptive ( oral , implant , injection ) diaphragm condom spermicide . 5 . Pregnancy lactation . 6 . Participation another trial EAA last 4 week beyond time 4 halflives medication use . In unlikely event subject already another clinical study EAA , study must stop subject may treat accord protocol ; latency time two study appear reasonable , acute intervention necessary EAA . Treatment may best do frame work protocol .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>